Skip to main content

Peer Review reports

From: The efficacy, safety and cost-effectiveness of hydroxychloroquine, sulfasalazine, methotrexate triple therapy in preventing relapse among patients with rheumatoid arthritis achieving clinical remission or low disease activity: the study protocol of a randomized controlled clinical Trial (ESCoRT study)

Original Submission
1 Jul 2020 Submitted Original manuscript
29 Jul 2020 Reviewed Reviewer Report
11 Sep 2020 Reviewed Reviewer Report
9 Oct 2020 Author responded Author comments - Juan Zhao
Resubmission - Version 2
9 Oct 2020 Submitted Manuscript version 2
9 Feb 2021 Reviewed Reviewer Report
17 Feb 2021 Author responded Author comments - Juan Zhao
Resubmission - Version 3
17 Feb 2021 Submitted Manuscript version 3
Publishing
18 Feb 2021 Editorially accepted
4 Mar 2021 Article published 10.1186/s12911-021-01449-2

You can find further information about peer review here.

Back to article page

BMC Medical Informatics and Decision Making

ISSN: 1472-6947

Contact us